CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 124 filers reported holding CARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,244 | -38.3% | 37,052 | +3.9% | 0.00% | – |
| Q2 2023 | $100,890 | -41.9% | 35,651 | +0.9% | 0.00% | – |
| Q1 2023 | $173,528 | -55.3% | 35,347 | -2.1% | 0.00% | -100.0% |
| Q4 2022 | $387,839 | +645.8% | 36,096 | +569.6% | 0.00% | – |
| Q3 2022 | $52,000 | +2.0% | 5,391 | -3.7% | 0.00% | – |
| Q2 2022 | $51,000 | -97.0% | 5,598 | -12.0% | 0.00% | -100.0% |
| Q1 2022 | $1,713,000 | +2214.9% | 6,364 | +3.3% | 0.00% | – |
| Q4 2021 | $74,000 | -21.3% | 6,163 | +0.8% | 0.00% | – |
| Q3 2021 | $94,000 | +23.7% | 6,112 | +13.9% | 0.00% | – |
| Q2 2021 | $76,000 | -52.5% | 5,366 | -27.3% | 0.00% | – |
| Q1 2021 | $160,000 | +27.0% | 7,386 | -10.4% | 0.00% | – |
| Q4 2020 | $126,000 | +14.5% | 8,246 | -4.6% | 0.00% | – |
| Q3 2020 | $110,000 | -51.1% | 8,640 | -34.3% | 0.00% | -100.0% |
| Q2 2020 | $225,000 | +8.7% | 13,147 | -16.5% | 0.00% | 0.0% |
| Q1 2020 | $207,000 | – | 15,743 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |